tag:blogger.com,1999:blog-5574479.post4895869839039578413..comments2024-03-28T16:45:51.051+00:00Comments on The IPKat: Bayer v Teva: Drug patent found "the result of standard and routine considerations" ([2021] EWHC 2690 (Pat))Verónica RodrÃguez Arguijohttp://www.blogger.com/profile/05763207846940036921noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-5574479.post-27670973362425840232021-11-29T05:42:11.682+00:002021-11-29T05:42:11.682+00:00The problem with this decision is that almost all ...The problem with this decision is that almost all research methodology is routine, it is the results of such routine research that are often surprising. So this case seems to be saying that if I run routine screens and discover that a tested compound cures all cancers, that discovery is not patentable because it is the result of routine research. Patents are intended to encourage research and that includes routine research that leads to unexpected results of value to the public at large.Peter Ghttps://www.blogger.com/profile/03352686204387152116noreply@blogger.com